Sep 30, 2017

Adaptimmune Q3 2017 Earnings Report

Total Revenue
$27.2M
Previous year: $2.42M
+1025.2%
EPS
-$0.00939
Previous year: -$0.26
-96.4%
Gross Profit
$3.15M
Cash and Equivalents
$145M
Free Cash Flow
$11.9M
Total Assets
$301M

Adaptimmune

Adaptimmune